Results 91 to 100 of about 3,407 (122)

DEVELOPMENT OF VIRCEL: A VIRTUAL COMMUNICATION ENGINEERING LABORATORY [PDF]

, 2017
Adedokun, Michael O., Atayero, A. A., Ogundeji, Ayodeji V.   +2 more
core  

Aptamer-ODN Chimeras: Enabling Cell-Specific ODN Targeting Therapy. [PDF]

Cells
Xia B, Zhu Q.
europepmc   +1 more source

Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery. [PDF]

Life (Basel)
Visan AI, Negut I.
europepmc   +1 more source

From Lab to Clinic: How Artificial Intelligence (AI) Is Reshaping Drug Discovery Timelines and Industry Outcomes. [PDF]

Pharmaceuticals (Basel)
Dermawan D, Alotaiq N.
europepmc   +1 more source

Essential issues and possible solutions in high-level synthesis [PDF]

, 1991
Gajski, Daniel D.
core  

Therapeutic proteins: developments, progress, challenges, and future perspectives. [PDF]

3 Biotech
Kumar V, Barwal A, Sharma N, Mir DS, Kumar P, Kumar V.   +5 more
europepmc   +1 more source

Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis. [PDF]

Nat Med
Klotz L, Smolders J, Lehto J, Matilainen M, Lütje L, Buchholz L, Albrecht S, Walter C, Varghese J, Wiendl H, Nylund M, Thomas C, Gardberg M, van den Bosch AMR, Airas L, Huitinga I, Kuhlmann T.   +16 more
europepmc   +1 more source

Wearable Medical Devices: Application Status and Prospects. [PDF]

Micromachines (Basel)
Wang X, Gao Y, Yuan Y, Wang Y, Liu A, Jia S, Yang W.   +6 more
europepmc   +1 more source

Altered behaviour and immune response in mice with NHLRC2 p.Asp148Tyr variant. [PDF]

Brain Behav Immun Health
Hiltunen AE, Kangas SM, Gondane A, Koivisto H, Salokas K, Heikkinen A, Salo MH, Röning T, Tallgren A, Glumoff V, Denis MC, Karagianni N, Myllyharju J, Varjosalo M, Tanila H, Itkonen HM, Rämet M, Uusimaa J, Hinttala R.   +18 more
europepmc   +1 more source

A review and outlook on expression of animal proteins in plants. [PDF]

Front Plant Sci
Tusé D, McNulty M, McDonald KA, Buchman LW.   +3 more
europepmc   +1 more source